A novel method combining EHR and GWAS data improves prediction of autoimmune disease progression from preclinical stages, ...

Increasing wildfire incidence, along with greater overall air pollution, may be contributing to risks for rheumatoid ...

A new study suggests that elevated triglyceride levels — the most common type of fat in the blood — could be a modifiable ...

The long-term incidence of MACE, VTE, and malignancies is low among patients with RA or UC receiving filgotinib, though a slight increase was observed among older patients.

Long-term glucocorticoid (GC) use among older adults with late-onset rheumatoid arthritis (LORA) remains prevalent, despite its known adverse effects, according to study results published in ACR Open ...

Psoriatic arthritis is a combination of psoriasis and arthritis symptoms. You may have skin and nail changes, joint pain and ...

Researchers at WashU Medicine have harnessed the internal circadian clock of the body to deliver medication for an ...

Objectives The impact of body mass index (BMI) on cardiovascular risk in rheumatoid arthritis (RA) is unclear. RA ...

AliveDx has submitted a 510(k) premarket notification seeking approval from the US Food and Drug Administration (FDA) for its MosaiQ AiPlex Connective Tissue Diseases (CTDplus) microarray. This ...

Triglycerides - the most common type of fat in blood - could be a potential modifiable risk factor for rheumatoid arthritis ...

The Switzerland-based firm's MosaiQ AiPlex Connective Tissue Diseases (CTDplus) assay is used to aid the diagnosis of autoimmune diseases.